Eczema, Atopic
16 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Effectiveness of a Topical Palmitoylethanolamide (PEA) Formulation (Levagen+) for Reducing Symptoms of Eczema (NCT05003453) | RDC Clinical Pty Ltd | 2021-11-29 |
| Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis (NCT03568136) | GWT-TUD GmbH | 2018-09-18 |
| A Study in Subjects With Moderate Atopic Dermatitis (NCT03175354) | Ralexar Therapeutics, Inc. | 2017-04-26 |
| Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis (NCT03050151) | Regeneron Pharmaceuticals | 2017-02-28 |
| Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4) (NCT00671528) | Organon and Co | 2009-07-01 |
| Long-term Safety of Protopic in Atopic Eczema (NCT00560378) | Astellas Pharma Inc | 1998-06-01 |
Track Eczema, Atopic automatically
Every clearance here is in the API, with alerts when new ones post.